A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Oral squamous cell carcinoma (OSCC) progresses from seemingly benign preneoplastic lesions, but understanding the epigenetic ...

Dynamic remodeling of the endomembrane system is a core biological process essential for maintaining cellular ...

Many Ugandans continue to face delayed diagnoses, limited access to specialised care, and low public awareness about eye ...

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Dr. Longwei Liu, a research assistant professor from the Mann Department of Biomedical Engineering and one of the study’s ...

At 71, Tina Knowles—the fashion designer, businesswoman, and mother of Beyoncé—made headlines not for her career, but for a ...

However, Shih and Kumar then used the term epithelioid trophoblastic tumor (ETT) to describe the neoplasms composed of chorionic-type intermediate-trophoblast cells (ITCs) [2]. Epithelioid ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

durable population of tumor-targeting T cells, according to a study published in The Journal of ImmunoTherapy of Cancer. “We designed the IL-12 cytokine factory to enhance immunotherapy ...